Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

If you have celiac disease, you also likely have a higher-than-normal risk of developing non-Hodgkin lymphoma. This may seem frightening, and it's certainly something that you should take ...

T-cell lymphoma is a type of lymphatic cancer that starts in the T lymphocytes (T cells), a type of white blood cell. T lymphocytes (T cells) and B lymphocytes (B cells) are two types of white blood ...

1 Primary leptomeningeal lymphoma occurs in approximately 7% of patients with PCNSL; however, leptomeningeal dissemination is observed in 7% to 42% of patients with parenchymal PCNSL. 1 Most patients ...

Major Finding: Pharmacologic inhibition of EZH2 sensitizes preclinical models of B cell lymphoma to T-cell immunotherapy. Concept: EZH2 inhibition enhances T-cell recruitment, T-cell–B-cell ...

Stage 4 diffuse large B-cell lymphoma (DLBCL) is a rapidly growing lymphoma affecting at least one other organ outside the lymphatic system. Cancer is the unusual growth and spread of cells within ...

Introduction: Diffuse large B-cell lymphoma (DLBCL) is an aggressive form of non-Hodgkin ... T-cell infiltrate and predominantly polytypic plasmacytosis, presenting as multifocal plasma ...

You may also hear this type of seizure called a partial seizure. You can find out about focal seizures on our webpage. Someone having a focal seizure may not be aware of their surroundings or what ...